| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.091 | 0.06 |